Search results
Author(s):
Gianluca Campo
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
Added:
6 months ago
Source:
Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time…
View more
Michael G Kirby
Job title: Visiting Professor to the Faculty of Health and Human Sciences
Author
Yiran Luo
Author
Tianzong Li
Author
Husam Abdel-Qadir
Job title: Cardiologist
Author
Ali Ahmed
Research Area(s) / Expertise:
Job title: Director of the Center for Health and Aging
Author
Enxi Quan
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Which interventional cardiology studies will have the greatest impact at ESC 2024?Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated hot line studies set to be unveiled at ESC Congress 2024. Get their in-depth analysis of the studies and gain invaluable insights ahead of the curve.ESC Congress…
View more
Bin Zhang
Author